Anaphylaxis to mivacurium.
Baird
M B
MB
Department of Anaesthesia, Auckland Hospital, New Zealand.
Futter
M
M
D000707:Anaphylaxis / Q000139:chemically induced*; D002648:Child; D053818:Chymases; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D007546:Isoquinolines / Q000009:adverse effects*; D008297:Male; D000077590:Mivacurium; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D012697:Serine Endopeptidases / Q000097:blood; D053802:Tryptases
D018836:Inflammation Mediators; D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D000077590:Mivacurium; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases